Media Summary: Robert Lionberger, Ph.D., Director of the Office of Research and Standards in the Office of What is the difference between brand name and When you've got a cold and need some medicine, do you ever wonder if there's a difference between branded and non-branded ...

The Science Of The Generic - Detailed Analysis & Overview

Robert Lionberger, Ph.D., Director of the Office of Research and Standards in the Office of What is the difference between brand name and When you've got a cold and need some medicine, do you ever wonder if there's a difference between branded and non-branded ... This workshop focused on common issues seen in abbreviated new drug applications (ANDAs), link GDUFA Lei Zhang, PhD, Deputy Director for the Office of Regulatory Commissioner of Food and Drugs, Robert M. Califf MD, MACC, delivers his Keynote Address to the 2023 Advancing

The purpose of this public workshop is to communicate how FDA's Any decisions we make, whether about vaccines, therapeutics, or anything else -- will be based on

Photo Gallery

Unmet needs in regulatory science for generic drugs
Brand Name vs. Generic
Science in Seconds - Generic Drugs
Are Branded Drugs Better? | Earth Science
Advancing Generic Drug Development: Translating Science to Approval – Day 1 – Session 2
Advancing Generic Drug Development: Translating Science to Approval, Day One Closing Remarks
Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 1 – Part 1
Cutting Edge Science in Complex Generics
Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 2
Advancing Generic Drug Development: Translating Science to Approval - Day 1 – Keynote and Session 1
Generic Industry Challenge Perspectives - GDUFA Science and Research Initiatives Public Workshop
Dr. Hahn's Remarks to “Advancing Innovative Science in Generic Drug Development” Workshop 9/29/2020
View Detailed Profile
Unmet needs in regulatory science for generic drugs

Unmet needs in regulatory science for generic drugs

Robert Lionberger, Ph.D., Director of the Office of Research and Standards in the Office of

Brand Name vs. Generic

Brand Name vs. Generic

What is the difference between brand name and

Science in Seconds - Generic Drugs

Science in Seconds - Generic Drugs

What are

Are Branded Drugs Better? | Earth Science

Are Branded Drugs Better? | Earth Science

When you've got a cold and need some medicine, do you ever wonder if there's a difference between branded and non-branded ...

Advancing Generic Drug Development: Translating Science to Approval – Day 1 – Session 2

Advancing Generic Drug Development: Translating Science to Approval – Day 1 – Session 2

This workshop focused on common issues seen in abbreviated new drug applications (ANDAs), link GDUFA

Advancing Generic Drug Development: Translating Science to Approval, Day One Closing Remarks

Advancing Generic Drug Development: Translating Science to Approval, Day One Closing Remarks

Lei Zhang, PhD, Deputy Director for the Office of Regulatory

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 1 – Part 1

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 1 – Part 1

Commissioner of Food and Drugs, Robert M. Califf MD, MACC, delivers his Keynote Address to the 2023 Advancing

Cutting Edge Science in Complex Generics

Cutting Edge Science in Complex Generics

FDA discusses topics in cutting edge

Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 2

Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 2

The purpose of this public workshop is to communicate how FDA's

Advancing Generic Drug Development: Translating Science to Approval - Day 1 – Keynote and Session 1

Advancing Generic Drug Development: Translating Science to Approval - Day 1 – Keynote and Session 1

This workshop focused on common issues seen in abbreviated new drug applications (ANDAs), link GDUFA

Generic Industry Challenge Perspectives - GDUFA Science and Research Initiatives Public Workshop

Generic Industry Challenge Perspectives - GDUFA Science and Research Initiatives Public Workshop

Presentations discuss perspectives on

Dr. Hahn's Remarks to “Advancing Innovative Science in Generic Drug Development” Workshop 9/29/2020

Dr. Hahn's Remarks to “Advancing Innovative Science in Generic Drug Development” Workshop 9/29/2020

Any decisions we make, whether about vaccines, therapeutics, or anything else -- will be based on

Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 5

Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 5

This workshop focused on common issues seen in abbreviated new drug applications (ANDAs), link GDUFA